Definitive Contract HHSN272200500038C
Award Date 9/30/05
Potential Completion Date 9/6/13
Potential Value $20M
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Emigration Canyon, UT 84108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $14,207,063.00 cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the Department of Health and Human Services, to Myriad Genetics Inc., a molecular diagnostics company based in Salt Lake City, Utah. The contract is for the identification of therapeutic targets using proteomics technology. No set-aside was used, indicating open competition. The contract has a period of performance ending on September 15,...
- This federal contract award was issued by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Myriad RBM, Inc., a small business subsidiary of Myriad Genetics Inc. The $102,806.60 firm-fixed-price purchase order is for the Carefree Study, a major program involving assays. The contract has a completion date of September 6, 2018 and was awarded on September 7, 2017. Myriad Genetics Inc. is a for-profit molecular diagnostics company that specializes in genetic...
- This is a firm-fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Myriad RBM, Inc., a subsidiary of Myriad Genetics Inc. The contract has a ceiling value of $64,875.00 and a completion date of September 30, 2014. The contract is for "OTHER FUNCTIONS - CSF ASSAYS TESTING" services and does not have a set-aside designation, indicating open competition. The parent company, Myriad Genetics Inc., is a...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Myriad RBM, Inc. for the "MYRIAD RBM HUMANMAP V2.0 SCREENING" service. The contract has a ceiling value of $12,960.00 and a completion date of October 24, 2014. This purchase order was not set aside for any specific business type. Myriad RBM, Inc. is a subsidiary of the parent company Myriad Genetics Inc., which is a...
- Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., was awarded a delivery order valued at $30,000 by the National Cancer Institute on June 25, 2007, with a completion date of September 20, 2007. This firm fixed-price contract, which carries no set-aside designation, involves the delivery of chemical-biological study services to be performed at the awardee's facility in Emigration Canyon, Utah. The National Cancer Institute, part of the National Institutes of Health, funds...
- This is a $1,148,568.17 firm-fixed-price contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services (HHS), to Myriad RBM, Inc., a subsidiary of Myriad Genetics, Inc. The contract was set aside for small businesses and awarded under the Small Business Innovation Research (SBIR) program, Phase I. It is for biomedical (applied/exploratory) research and development, with a period of performance from September 30, 2008, to March 29, 2011. Based...
- This federal contract award was made by the Defense Health Agency (DHA) to Myriad Genetics Inc., a molecular diagnostic company headquartered in Salt Lake City, Utah. The $100,000.00 firm-fixed-price contract is for MYRIAD GENETIC TESTING services, specifically the company's ProLaris testing for prostate cancer. The contract has no set-aside designation, indicating open competition. This award is part of Myriad Genetics Inc.'s ongoing work providing specialized genetic testing services,...
- This contract was awarded by the Department of Defense's Medical Command (MEDCOM) to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc. The contract, valued at $75,124.60, is a Blanket Purchase Agreement (BPA) call for various genetic testing services, with an ultimate completion date of September 30, 2016. The contract is not designated as a set-aside. Myriad Genetic Laboratories, a for-profit organization specializing in personalized medicine and genetic testing services,...
- This is a federal contract award to Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., a for-profit organization specializing in personalized medicine and genetic testing services. The contract, awarded by the Department of Veterans Affairs (VA), is for the provision of Prolaris prostate cancer testing services for the VA's Salt Lake City Medical Center. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price of $52,954.00 and a performance period...
- This federal contract award is for VARIOUS GENETIC TESTING SERVICES provided by Myriad Genetic Laboratories Inc., a subsidiary of Myriad Genetics Inc., to the U.S. Army Medical Command (MEDCOM). The $95,000.00 Blanket Purchase Agreement (BPA) call contract is for firm fixed-price genetic testing services, with a period of performance through September 30, 2015. The contract does not have a set-aside designation, indicating Myriad Genetic Laboratories competed openly for the award. The primary...